Sector
PharmaceuticalsOpen
₹56Prev. Close
₹56Turnover(Lac.)
₹0.56Day's High
₹56Day's Low
₹5652 Week's High
₹124.2552 Week's Low
₹50Book Value
₹38.44Face Value
₹10Mkt Cap (₹ Cr.)
42.25P/E
27.59EPS
2.03Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 7.55 | 7.55 | 7.55 | 7.55 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 21.46 | 19.93 | 19.13 | 18.33 |
Net Worth | 29.01 | 27.48 | 26.68 | 25.88 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2019 |
---|---|---|
Revenue | 93.98 | 106.27 |
yoy growth (%) | -11.57 | |
Raw materials | -85.79 | -92.36 |
As % of sales | 91.29 | 86.91 |
Employee costs | -2.44 | -4.71 |
Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2019 |
---|---|---|
Profit before tax | 0.42 | 0.88 |
Depreciation | -0.03 | -0.05 |
Tax paid | -0.1 | -0.19 |
Working capital | 12.58 | |
Other operating items |
Y/e 31 Mar | Mar-2020 | Mar-2019 |
---|---|---|
Growth matrix (%) | ||
Revenue growth | -11.57 | |
Op profit growth | -27.47 | |
EBIT growth | -24.64 | |
Net profit growth | -54.28 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,766.2 | 134.52 | 4,23,770.54 | 1,181.05 | 0.76 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,958.35 | 76.3 | 1,58,175.47 | 594 | 0.5 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,486.75 | 25.8 | 1,20,075.94 | 1,438.15 | 0.87 | 4,134.87 | 360.72 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,183 | 59.05 | 1,07,722.35 | 485 | 0.88 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,434.1 | 51.93 | 1,00,425.74 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Hemant C Bhagat
Whole-time Director
Pranav H Bhagat
Director & CFO
Prachi Pranav Bhagat
Independent Director
Ravindra Gajanan Awati
Independent Director
Abha Praveen Doshi
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Chandra Bhagat Pharma Ltd
Summary
Chandra Bhagat Pharma Limited was incorporated as a Private Limited Company with the name Chandra Bhagat Pharma Private Limited at Mumbai on March 10, 2003. Consequent upon the conversion of the Company from Private Limited Company to Public Limited Company, the name of the Company was changed to Chandra Bhagat Pharma Limited on March 20, 2019.The Company incorporated in March, 2003 by Mr. Hemant Bhagat and Late. Shree Chandravadan Bhagat. On April 1, 2003, the Company acquired the going concern business of M/s. Chandra Bhagat Corporation, partnership firm along with all its assets and liabilities. Consequently, the Company issued equity shares to respective partners of M/s. Chandra Bhagat Corporation upon the acquisition of going concern business. Thereafter, the Promoter Mr. Hemant Bhagat continued the business on the footsteps of his father Late Shree Chandravadan Bhagat by focusing on marketing of life saving medicines like Antibiotics, Antineoplastic, Cardiovascular, Hormones etc. and set up the Companys marketing force to wider the product portfolio. Subsequently in 2004, the Promoters, Mr. Pranav Bhagat son of Mr. Hemant Bhagat, joined the business and decided to market the pharmaceuticals and special chemical products in domestic as well as in international market.The Company is engaged in the business of marketing pharmaceutical critical care & health care products. For which it obtained necessary approvals from FDA for getting the formulations manufacture from contr
Read More
The Chandra Bhagat Pharma Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹56 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Chandra Bhagat Pharma Ltd is ₹42.25 Cr. as of 09 May ‘25
The PE and PB ratios of Chandra Bhagat Pharma Ltd is 27.59 and 1.46 as of 09 May ‘25
The 52-week high/low is the highest and lowest price at which a Chandra Bhagat Pharma Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Chandra Bhagat Pharma Ltd is ₹50 and ₹124.25 as of 09 May ‘25
Chandra Bhagat Pharma Ltd's CAGR for 5 Years at 5.82%, 3 Years at -24.48%, 1 Year at -54.93%, 6 Month at -21.67%, 3 Month at -12.50% and 1 Month at 1.82%.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.